Sterile Fill-Finish / Oral Solid Development, Manufacturing & Packaging – CDMO
Avara had rapidly created a multi-region manufacturing footprint through a series of Big Pharma facility acquisitions. The company opted to invest in its North American and European trade show presence to showcase its breadth of sterile and small molecule drug product manufacturing services and better connect with an international audience.
